Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01.
Prinssen HM, Molthoff CF, Verheijen RH, Broadhead TJ, Kenemans P, Roos JC, Davies Q, van Hof AC, Frier M, den Hollander W, Wilhelm AJ, Baker TS, Sopwith M, Symonds EM, Perkins AC.
Prinssen HM, et al. Among authors: den hollander w.
Cancer Immunol Immunother. 1998 Sep;47(1):39-46. doi: 10.1007/s002620050502.
Cancer Immunol Immunother. 1998.
PMID: 9755877
Free PMC article.